{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:44:22Z","timestamp":1762868662087},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873679","81770964"],"award-info":[{"award-number":["81873679","81770964"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1038\/s41433-021-01693-w","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T15:02:40Z","timestamp":1634310160000},"page":"2106-2110","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Outcome of salvage intra-arterial chemotherapy for recurrent retinoblastoma"],"prefix":"10.1038","volume":"36","author":[{"given":"Jiakai","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaohui","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuming","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingyi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiquan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xunda","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"1693_CR1","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1136\/bjo.2008.150292","volume":"93","author":"T Kivel\u00e4","year":"2009","unstructured":"Kivel\u00e4 T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93:1129\u201331.","journal-title":"Br J Ophthalmol."},{"key":"1693_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1146\/annurev-med-061312-123455","volume":"65","author":"DH Abramson","year":"2014","unstructured":"Abramson DH. Retinoblastoma: saving life with vision. Annu Rev Med. 2014;65:171\u201384.","journal-title":"Annu Rev Med."},{"key":"1693_CR3","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1001\/archophthalmol.2011.5","volume":"129","author":"YP Gobin","year":"2011","unstructured":"Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol. 2011;129:732\u20137.","journal-title":"Arch Ophthalmol."},{"key":"1693_CR4","doi-asserted-by":"publisher","first-page":"740","DOI":"10.4103\/ijo.IJO_866_19","volume":"67","author":"FP Manjandavida","year":"2019","unstructured":"Manjandavida FP, Stathopoulos C, Zhang J, Honavar SG, Shields CL. Intra-arterial chemotherapy in retinoblastoma - A paradigm change. Indian J Ophthalmol. 2019;67:740\u201354.","journal-title":"Indian J Ophthalmol."},{"key":"1693_CR5","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.ophtha.2014.01.026","volume":"121","author":"CL Shields","year":"2014","unstructured":"Shields CL, Manjandavida FP, Lally SE, Pieretti G, Arepalli SA, Caywood EH, et al. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma. Ophthalmology. 2014;121:1453\u201360.","journal-title":"Ophthalmology."},{"key":"1693_CR6","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1136\/bjophthalmol-2016-309298","volume":"101","author":"FL Munier","year":"2017","unstructured":"Munier FL, Mosimann P, Puccinelli F, Gaillard M-C, Stathopoulos C, Houghton S, et al. First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 years of treatment. Br J Ophthalmol. 2017;101:1086\u201393.","journal-title":"Br J Ophthalmol."},{"key":"1693_CR7","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00345-016-1941-0","volume":"35","author":"A Lorch","year":"2017","unstructured":"Lorch A, Beyer J. High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how. World J Urol. 2017;35:1177\u201384.","journal-title":"World J Urol."},{"key":"1693_CR8","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00277-018-3304-y","volume":"97","author":"JE Meg\u00edas-Vericat","year":"2018","unstructured":"Meg\u00edas-Vericat JE, Mart\u00ednez-Cuadr\u00f3n D, Sanz M\u00c1, Montesinos P. Salvage regimens using conventional chemotherapy agents for relapsed\/refractory adult AML patients: a systematic literature review. Ann Hematol. 2018;97:1115\u201353.","journal-title":"Ann Hematol."},{"key":"1693_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/13816810.2016.1244695","volume":"38","author":"DH Abramson","year":"2017","unstructured":"Abramson DH, Fabius AWM, Francis JH, Marr BP, Dunkel IJ, Brodie SE, et al. Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma. Ophthalmic Genet. 2017;38:16\u201321.","journal-title":"Ophthalmic Genet."},{"key":"1693_CR10","doi-asserted-by":"publisher","first-page":"e0197081","DOI":"10.1371\/journal.pone.0197081","volume":"13","author":"JH Francis","year":"2018","unstructured":"Francis JH, Levin AM, Zabor EC, Gobin YP, Abramson DH. Ten-year experience with ophthalmic artery chemosurgery: ocular and recurrence-free survival Vavvas DG (ed). Plos One. 2018;13:e0197081.","journal-title":"Plos One."},{"key":"1693_CR11","doi-asserted-by":"crossref","unstructured":"Ravindran K, Dalvin LA, Pulido JS, Brinjikji W. Intra-arterial chemotherapy for retinoblastoma: an updated systematic review and meta-analysis. J. Neurointerventional Surg. 2019;11:1266\u201372.","DOI":"10.1136\/neurintsurg-2019-014909"},{"key":"1693_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4406-6","volume":"18","author":"Q Chen","year":"2018","unstructured":"Chen Q, Zhang B, Dong Y, Mo X, Zhang L, Huang W, et al. Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis. BMC Cancer. 2018;18:486.","journal-title":"BMC Cancer."},{"key":"1693_CR13","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.ophtha.2014.11.029","volume":"122","author":"JH Francis","year":"2015","unstructured":"Francis JH, Abramson DH, Gobin YP, Marr BP, Tendler I, Brodie SE, et al. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma. Ophthalmology. 2015;122:1016\u201322.","journal-title":"Ophthalmology."},{"key":"1693_CR14","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jfo.2015.03.004","volume":"38","author":"CL Shields","year":"2015","unstructured":"Shields CL, Say EAT, Pointdujour-Lim R, Cao C, Jabbour PM, Shields JA. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy. J Fr Ophtalmol. 2015;38:542\u20139.","journal-title":"J Fr Ophtalmol."},{"key":"1693_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00417-015-3202-0","volume":"254","author":"JH Lee","year":"2016","unstructured":"Lee JH, Han JW, Hahn SM, Lyu CJ, Kim DJ, Lee SC. Combined intravitreal melphalan and intravenous\/intra-arterial chemotherapy for retinoblastoma with vitreous seeds. Graefes Arch Clin Exp Ophthalmol. 2016;254:391\u20134.","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"1693_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000491580","volume":"5","author":"LA Dalvin","year":"2019","unstructured":"Dalvin LA, Kumari M, Essuman VA, Shohelly Shipa S, Ancona-Lezama D, Lucio-Alvarez JA, et al. Primary intra-arterial chemotherapy for retinoblastoma in the intravitreal chemotherapy era: five years of experience. Ocul Oncol Pathol. 2019;5:139\u201346.","journal-title":"Ocul Oncol Pathol."},{"key":"1693_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3928\/01913913-20160719-04","volume":"53","author":"CL Shields","year":"2016","unstructured":"Shields CL, Alset AE, Say EAT, Caywood E, Jabbour P, Shields JA. Retinoblastoma control with primary intra-arterial chemotherapy: outcomes before and during the intravitreal chemotherapy era. J Pediatr Ophthalmol Strabismus. 2016;53:275\u201384.","journal-title":"J Pediatr Ophthalmol Strabismus."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01693-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01693-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01693-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T08:04:39Z","timestamp":1666166679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01693-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1693"],"URL":"https:\/\/doi.org\/10.1038\/s41433-021-01693-w","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"15 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}